This is an independent comparison for prospective users; NoVo is not affiliated with the other tools named, and product features and pricing change — verify current specifics on each provider’s own site.
Volland is a well-regarded options-analytics platform focused on dealer exposure — gamma, and higher-order greeks like vanna and charm that most retail tools skip entirely. If your interest is understanding how hedging pressure builds across a whole options complex, it is a genuinely deep instrument.
The core difference: analytics vs. analytics + execution
Volland is an analytics product. It shows you where exposure sits; you then carry that read somewhere else — a broker window, a chart platform — and place the trade yourself. That handoff is where scalps die: you saw the level, then fumbled the strike, or hesitated, or forgot the stop.
NoVo is an execution cockpit. It maps the same class of structure — net GEX regime, the gamma flip, call and put walls, gravity, expected move — and then, when you decide to take the trade, executes it in one click inside your own brokerage account: it picks the strike, sizes to your risk settings, arms the protective stop, and manages the exit ladder.
Where each fits
Choose a pure-analytics platform if you want the deepest possible exposure modelling across many underlyings and you already have execution solved. Choose NoVo if you specifically scalp SPY 0DTE and the thing costing you money is not the analysis — it is the seconds between seeing the level and getting filled.
Analytics tells you where the levels are. NoVo tells you where the levels are — then executes the trade you chose, sizes it, and manages the exit. You decide every entry; the tool does the mechanics.
One tool instead of two subscriptions
The practical argument is cost and friction. A dealer-flow analytics subscription plus a separate execution layer is two bills and two tabs that do not talk to each other. NoVo is both halves in one place — which is the entire reason it exists.
The honest caveats
NoVo is not a broad research terminal. It is built for SPY 0DTE/1DTE scalping, so if you want analytics across dozens of tickers, equities screening and macro commentary, a dedicated research platform covers far more ground. NoVo also does not remove risk: options trading carries substantial risk of loss, no outcome is guaranteed, and you should run it in paper mode before committing real capital. And NoVo never enters a trade on its own — if you want something that takes positions while you are away, this is not that.